Triple
T10214594
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Renflexis |
E242409
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | infliximab biosimilar |
C7487
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: infliximab biosimilar Context triple: [Renflexis, instanceOf, infliximab biosimilar]
-
A.
biologic medicinal product
chosen
A biologic medicinal product is a therapeutic substance derived from living organisms or their components, such as proteins, cells, or tissues, used to prevent, diagnose, or treat diseases.
-
B.
biologic therapy
Biologic therapy is a treatment that uses substances made from living organisms or their derivatives to target specific components of the immune system or disease processes.
-
C.
pegylated interferon beta-1a
Pegylated interferon beta-1a is a long-acting, pegylated form of interferon used as a disease-modifying therapy to reduce relapses and slow progression in patients with relapsing forms of multiple sclerosis.
-
D.
Bruton tyrosine kinase inhibitor
A Bruton tyrosine kinase inhibitor is a targeted small-molecule drug that blocks BTK signaling in B cells to disrupt pathways critical for their activation, proliferation, and survival, primarily used in the treatment of certain B-cell malignancies and autoimmune diseases.
-
E.
angiopoietin-2 inhibitor
An angiopoietin-2 inhibitor is a therapeutic agent that selectively blocks the activity of angiopoietin-2 to stabilize blood vessels, reduce pathological angiogenesis, and modulate vascular inflammation in diseases such as cancer and ocular disorders.
- F. None of above.
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d381ae26c48190985abd0e25ee5d04 |
completed | April 6, 2026, 9:49 a.m. |
Created at: April 6, 2026, 11:04 a.m.